FDA approves Teva's generic nasal spray to treat opioid overdose

Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration (FDA) to market its generic nasal spray for opioid overdose, the health regulator said.

from Reuters: Health News https://reut.rs/2XsFo5w
via IFTTT